Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms DG01 |
Target |
Mechanism GSPT1 degraders(G1 to S phase transition 1 degraders), SRD5A3 inhibitors(steroid 5 alpha-reductase 3 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Phase 1 | CN | 19 Nov 2024 | |
Liver Cancer | IND Approval | CN | 02 Aug 2024 | |
Metastatic castration-resistant prostate cancer | IND Approval | CN | 02 Aug 2024 |